Medical Developments International LtdShs Aktie
0,51USD | 0,26USD | 104,68% |
WKN: A0BLXB / ISIN: AU000000MVP2
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 65 | 68 | 0 | 0 | 0 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,35 | 0,37 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. AUD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 26 | 47 | 34 | 43 | 26 |
Summe Anlagevermögen | 69 | 53 | 67 | 67 | 38 |
Summe Aktiva | 95 | 100 | 101 | 109 | 64 |
Bilanz (in Mio. AUD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 52 | 32 | 44 | 28 | 18 |
Summe Eigenkapital | 43 | 68 | 57 | 81 | 46 |
Summe Passiva | 95 | 100 | 101 | 109 | 64 |
Adresse
4 Caribbean Drive, 3179 Scoresby | |
Telefon | +61 (3) 9547-1888 |
Fax | +61 (3) 9547-0262 |
Internet | http://www.medicaldev.com |
Management
Anastasia Tan
Head-Operations & Supply Chain |
Anita James
Chief Financial Officer |
Brent MacGregor
Chief Executive Officer |
Christine Emmanuel-Donnelly
Independent Non-Executive Director |
Damian Meagher
Head-Quality & Regulatory Affairs |
Gordon Naylor
Non-Executive Chairman |
Leon Gregory Hoare
Independent Non-Executive Director |
Richard Betts
Non-Executive Director |
Russell Basser
Director |
Scott Courtney
Chief Scientific Officer |
Sue Anne Yee
Head-Medical Affairs & Clinical Development |
Tara Eaton
Secretary & General Counsel |
Tony Wheal
Head-People & Culture |